Skip to main content

Reviva Pharmaceuticals Holdings, Inc 10-K for FY2023

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

10-K 2024-04-15 For: 2023-12-31
View Original
Added on April 07, 2026

About this 10-K

Reviva Pharmaceuticals Holdings, Inc filed this 10-K on April 15, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$39.26M
compared with a net loss of $28.26M a year earlier